A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

Clinical trial NCT04442503 · COMPLETED

Trial details

NCT number: NCT04442503
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depression, Postpartum

Start date: 2020-06-08
Primary completion: 2022-03-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.